InvestorsHub Logo
Followers 52
Posts 1195
Boards Moderated 0
Alias Born 12/31/2013

Re: iclight post# 41055

Friday, 09/18/2015 11:54:03 AM

Friday, September 18, 2015 11:54:03 AM

Post# of 730111
Oversimplified explanation that completely ignores the role of cancer treatment and more specifically, at what stage in the natural history of cancer can a given intervention succeed.

Stage 4 patients are a heterogeneous group of patients that can be subclassified based on how far along they have progressed and how functional their bodies are.

Eventually they all end up with the same outcome but some will get there in a day and some in a month.

There is a point of no return. NO therapy can bring you back once you've crossed that point. Patients that are past that point should not be included in this trial. They are too sick to benefit from this or any antineoplastic treatment because main their problem is no longer cancer. Their problem is that their bodies are in the midst of a shutdown process. Their reserves are exhausted.

You need to be able understand which patients can be helped by dcvax. Not all stage 4 patients are the same.

Its NOT about massaging data or cherry picking patients in the negative way that uneducated investors/bloggers often use as an argument.

When you spew out medical terminology without a deeper understanding you mislead other investors that are wowed by your falsely portrayed expertise.

To sum it up in simpler terms, your post is full of...

icbs
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News